Invuity Bolsters Executive Team; Adds Industry Veterans in Key Finance and Commercial Roles
Michael J. Gandy named SAN FRANCISCO, Feb. 13, 2013 /PRNewswire/ -- Invuity, a leading developer of advanced visualization devices for minimally invasive surgery, announced that it has named Michael J. Gandy as Chief Financial Officer and Robert E. Gerberich as Vice President, Sales & Marketing. Both have more than two decades of experience in the medical device industry and will report directly to Invuity CEO Philip Sawyer.
“We have reached a key point in our corporate and commercial development where it is critical to expand our executive team. Both Mike and Bob bring extensive industry experience combined with a strategic mindset and strong leadership to Invuity’s dynamic organization,” Sawyer commented. “2013 will be a notable year at Invuity as we launch novel new products, build out the company’s infrastructure and capitalize on the rapid growth we are experiencing in our initial markets. Our strengthened executive team will refine and execute the strategies to establish our proprietary Eigr (pronounced eye-gr) technology as a true platform technology capable of driving growth across multiple surgical specialties and enabling new minimally invasive and minimal access surgical techniques to improve patient outcomes.”
Gandy has spent more than 20 years leading the finance and accounting teams at both private and publicly traded medical technology companies. He came to Invuity from Newark, CA-based Novasys Medical, Inc., a medical device company focused on women’s health, where he served as CFO. Prior to Novasys, Gandy served as CFO at Baxano, Inc., a San Jose-based spinal device company, where he had broad functional responsibility for finance and accounting, including oversight of venture funding activities. Gandy also served as Vice President, Finance and CFO at privately held Bacchus Vascular, leading the finance and accounting groups leading up to the successful acquisition of the company by Covidian in 2009. Prior to that role, he held positions in financial management at a number of private and public companies, including nine years of increasing financial management at a division of NYSE-traded Guidant Corporation.
Gerberich has served in sales and marketing leadership roles for two decades within the surgical device and medical aesthetics segments of the life sciences market. He comes to Invuity from Dallas-based Primcogent Solutions, Inc., where he served as Senior Vice President of Global Sales and Field Development leading the commercialization of innovative low-level laser therapy (LLLT) technologies. Prior to that, Gerberich spent six years as President of San Ramon, CA-based UltraShape NA Inc. and head of global sales for Israel-based UltraShape Ltd. (acquired by Syneron Medical Ltd.) where he launched the first non-surgical focused ultrasound body sculpting technology. Gerberich also served as VP Marketing and Sales at Hayward, CA-based Thermage, Inc. (now Solta Medical) where he was responsible for launching the first non-invasive radiofrequency tissue tightening technology and led the effort in building sales from zero to $50 million. He also led dynamic and fast growing sales organizations at several other medical device companies representative of Invuity’s target markets.
“Mike and Bob bring a wealth of experience to Invuity, and we are delighted to have them on board to complement the rest of our talented executive team,” commented Philip Sawyer.
About Eigr
Eigr Technology combines injection-molded optical lens waveguide technology with integrated microstructures to control illumination output to the operative space. Eigr projects thermally cool, brilliant white light broadly and uniformly within the deepest darkest surgical cavities to provide unsurpassed visualization while virtually eliminating shadows, back reflection, glare and thermal hazards.
About Invuity
Invuity develops advanced medical devices to dramatically improve access and visualization in minimally invasive and minimal access surgeries. The company’s products incorporate its proprietary Eigr technology into sophisticated hand-held illumination devices and illuminated access systems for a variety of surgical specialties including spine, orthopedics, breast and thyroid oncology and plastic surgery. The company is headquartered in San Francisco, CA. For more information, visit www.invuity.com.
SOURCE Invuity
SAN FRANCISCO, Feb. 13, 2013 /PRNewswire/ -- Invuity, a leading developer of advanced visualization devices for minimally invasive surgery, announced that it has named Michael J. Gandy as Chief Financial Officer and Robert E. Gerberich as Vice President, Sales & Marketing. Both have more than two decades of experience in the medical device industry and will report directly to Invuity CEO Philip Sawyer.
“We have reached a key point in our corporate and commercial development where it is critical to expand our executive team. Both Mike and Bob bring extensive industry experience combined with a strategic mindset and strong leadership to Invuity’s dynamic organization,” Sawyer commented. “2013 will be a notable year at Invuity as we launch novel new products, build out the company’s infrastructure and capitalize on the rapid growth we are experiencing in our initial markets. Our strengthened executive team will refine and execute the strategies to establish our proprietary Eigr (pronounced eye-gr) technology as a true platform technology capable of driving growth across multiple surgical specialties and enabling new minimally invasive and minimal access surgical techniques to improve patient outcomes.”
Gandy has spent more than 20 years leading the finance and accounting teams at both private and publicly traded medical technology companies. He came to Invuity from Newark, CA-based Novasys Medical, Inc., a medical device company focused on women’s health, where he served as CFO. Prior to Novasys, Gandy served as CFO at Baxano, Inc., a San Jose-based spinal device company, where he had broad functional responsibility for finance and accounting, including oversight of venture funding activities. Gandy also served as Vice President, Finance and CFO at privately held Bacchus Vascular, leading the finance and accounting groups leading up to the successful acquisition of the company by Covidian in 2009. Prior to that role, he held positions in financial management at a number of private and public companies, including nine years of increasing financial management at a division of NYSE-traded Guidant Corporation.
Gerberich has served in sales and marketing leadership roles for two decades within the surgical device and medical aesthetics segments of the life sciences market. He comes to Invuity from Dallas-based Primcogent Solutions, Inc., where he served as Senior Vice President of Global Sales and Field Development leading the commercialization of innovative low-level laser therapy (LLLT) technologies. Prior to that, Gerberich spent six years as President of San Ramon, CA-based UltraShape NA Inc. and head of global sales for Israel-based UltraShape Ltd. (acquired by Syneron Medical Ltd.) where he launched the first non-surgical focused ultrasound body sculpting technology. Gerberich also served as VP Marketing and Sales at Hayward, CA-based Thermage, Inc. (now Solta Medical) where he was responsible for launching the first non-invasive radiofrequency tissue tightening technology and led the effort in building sales from zero to $50 million. He also led dynamic and fast growing sales organizations at several other medical device companies representative of Invuity’s target markets.
“Mike and Bob bring a wealth of experience to Invuity, and we are delighted to have them on board to complement the rest of our talented executive team,” commented Philip Sawyer.
About Eigr
Eigr Technology combines injection-molded optical lens waveguide technology with integrated microstructures to control illumination output to the operative space. Eigr projects thermally cool, brilliant white light broadly and uniformly within the deepest darkest surgical cavities to provide unsurpassed visualization while virtually eliminating shadows, back reflection, glare and thermal hazards.
About Invuity
Invuity develops advanced medical devices to dramatically improve access and visualization in minimally invasive and minimal access surgeries. The company’s products incorporate its proprietary Eigr technology into sophisticated hand-held illumination devices and illuminated access systems for a variety of surgical specialties including spine, orthopedics, breast and thyroid oncology and plastic surgery. The company is headquartered in San Francisco, CA. For more information, visit www.invuity.com.
SOURCE Invuity
